The latest news on fibromyalgia syndrome and chronic fatigue syndrome is posted below in support of Fibromyalgia Network’s mission to educate patients and the media with ad-free reporting.
The U.S. Food and Drug Administration (FDA) approves Cymbalta (duloxetine) on June 16 for treating fibromyalgia.Read the complete article.
The quest for humans to escape cold weather during their retirement years may have a physiological basis.Read the complete article.
This study looks at why the medical costs per year of fibromyalgia patients dropped after being diagnosed.Read the complete article.
Growth hormone secretion from the brain’s hypothalamus-pituitary system is substantially low in one-third of fibromyalgia patients.Read the complete article.
NY Times article questions validity of fibromyalgia and prompts response from medical community.Read the complete article.
You may be wondering: “What form of exercise is best and how do I get started?”Read the complete article.
Can the application of heat realistically tone down the central nervous system pain that is the hallmark of fibromyalgia?Read the complete article.
This clinical trial by German doctors demonstrates how doctor-patient relationships can improve with a little education.Read the complete article.
Fibromyalgia patients who believe their doctors are serious about treating their symptoms may improve both physically and psychologically.Read the complete article.
Being able to use one medication to treat fibromyalgia would be ideal, but may be unrealistic.Read the complete article.